Hittade 2 uppsatser som matchar ovanstående sökkriterier.
Sammanfattning : BackgroundToday, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are believed to have increased survival rate in patients affected by peritoneal carcinomatosis. However, cured patients and long-term survivors have ongoing health care problem after their treatment is successfully completed. LÄS MER
2. Patient-Reported Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyMagister-uppsats, Mälardalens högskola/Hälsa och välfärd
Sammanfattning : abstract Background: In the past, peritoneal carcinomatosis which develops after dissemination from digestive cancers has been regarded as a terminal disease that would result in the death regardless of the nature of intervention. Today, hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) is an optional curative treatment reported to improve a rate of survival for selected patients. LÄS MER